One of them, with an IC50 of 2.7nM for HDAC6 and 710nM for HDAC2, showed the greatest efficacy in limiting GBM cell growth in vitro and in vivo and in overcoming TMZ resistance [322]. Here, HDAC6 is linked to glioblastoma.